Resveratrol targeting MDM2/P53/PUMA axis to inhibit colonocyte apoptosis in DSS-induced ulcerative colitis mice.

Front Pharmacol · 2025 · PMC12075554 · PMID 40371345

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Among the Resveratrol-treated groups, 50 nM showed a trend toward improving DNA fragmentation and mitochondrial potential, though not significantly.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.